Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Chenodiol by Leadiant Biosciences for Cerebrotendinous Xanthomatosis: Likelihood of Approval
Chenodiol is under clinical development by Leadiant Biosciences and currently in Phase III for Cerebrotendinous Xanthomatosis. According to GlobalData, Phase...
Data Insights
Chenodiol by Mirum Pharmaceuticals for Cerebrotendinous Xanthomatosis: Likelihood of Approval
Chenodiol is under clinical development by Mirum Pharmaceuticals and currently in Pre-Registration for Cerebrotendinous Xanthomatosis. According to GlobalData, Pre-Registration drugs...